Boyd Watterson Asset Management LLC Bristol Myers Squibb CO Transaction History

Boyd Watterson Asset Management LLC

$331 Million
Q3 2025

A detailed history of Boyd Watterson Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boyd Watterson Asset Management LLC holds 42,865 shares of BMY stock, worth $2.01 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

42,865

Previous 42,865 -0.0%

Holding current value

$2.01 Million

Previous $1.98 Million 2.57%

% of portfolio

0.58%

Previous 0.64%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	SELL	$44.12 - $59.6 $46,546 - $62,878	-1,055 Reduced 2.4%	42,865 $1.98 Million
Q1 2025 May 06, 2025	BUY	$53.9 - $63.11 $80,850 - $94,665	1,500 Added 3.54%	43,920 $2.68 Million
Q3 2024 Oct 22, 2024	SELL	$39.66 - $51.75 $5,948 - $7,762	-150 Reduced 0.35%	42,420 $2.2 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $6,238 - $8,213	-155 Reduced 0.36%	42,570 $1.77 Million
Q1 2024 Apr 29, 2024	SELL	$47.98 - $54.4 $37,184 - $42,160	-775 Reduced 1.78%	42,725 $2.32 Million
Q4 2023 Feb 02, 2024	SELL	$48.48 - $57.85 $145,440 - $173,550	-3,000 Reduced 6.45%	43,500 $2.23 Million
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $175,985 - $196,779	-3,040 Reduced 6.14%	46,500 $2.7 Million
Q4 2022 Jan 18, 2023	SELL	$68.48 - $81.09 $205,440 - $243,270	-3,000 Reduced 5.71%	49,540 $0
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $279,587 - $307,923	-3,850 Reduced 6.83%	52,540 $4.05 Million
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $21,518 - $25,802	350 Added 0.62%	56,390 $4.12 Million
Q1 2021 Apr 27, 2021	BUY	$59.34 - $66.74 $8,901 - $10,011	150 Added 0.27%	56,040 $3.54 Million
Q4 2020 Jan 20, 2021	SELL	$57.74 - $65.43 $973,496 - $1.1 Million	-16,860 Reduced 23.18%	55,890 $3.47 Million
Q3 2020 Oct 23, 2020	BUY	$57.43 - $63.64 $4.18 Million - $4.63 Million	72,750 New	72,750 $4.39 Million
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $157,296 - $228,587	-3,390 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$49.21 - $64.19 $166,821 - $217,604	3,390 New	3,390 $218,000
Q2 2019 Jul 24, 2019	SELL	$44.62 - $49.34 $223,590 - $247,242	-5,011 Closed	0 $0
Q1 2019 Apr 09, 2019	BUY	$45.12 - $53.8 $226,096 - $269,591	5,011 New	5,011 $239,000
Q4 2018 Jan 16, 2019	SELL	$48.76 - $63.23 $185,824 - $240,969	-3,811 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$50.53 - $62.98 $3,284 - $4,093	65 Added 1.74%	3,811 $211,000
Q1 2018 Apr 19, 2018	SELL	$59.92 - $68.98 $1,797 - $2,069	-30 Reduced 0.79%	3,746 $237,000
Q4 2017 Jan 11, 2018	SELL	$59.94 - $65.35 $2,937 - $3,202	-49 Reduced 1.28%	3,776 $231,000
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $211,254 - $243,805	3,825	3,825 $244,000

Others Institutions Holding BMY

# of Institutions

2,679

Shares Held

1.58B

Call Options Held

28.2M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyd Watterson Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boyd Watterson Asset Management LLC with notifications on news.

Account

Boyd Watterson Asset Management LLC Bristol Myers Squibb CO Transaction History